Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
On WRAL Monday at 6: Known carcinogens hiding in your childâs classroom? WRAL Investigates why some local schools are refusing to take action
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Matinas Biopharma Hl
(NY:
MTNB
)
0.1038
+0.0007 (+0.68%)
Streaming Delayed Price
Updated: 10:24 AM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Matinas Biopharma Hl
< Previous
1
2
3
Next >
Earnings Preview For Matinas BioPharma Hldgs
March 07, 2022
Matinas BioPharma Hldgs (AMEX:MTNB) is set to give its latest quarterly earnings report on Tuesday, 2022-03-08. Here's what investors need to know before the announcement....
Via
Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
March 06, 2022
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
December 08, 2021
We've reached the halfway point of the week and there's no slowing down as we dive into the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
Exposures
Product Safety
Earnings Scheduled For August 10, 2021
August 10, 2021
Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:...
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Exposures
Product Safety
51 Biggest Movers From Yesterday
January 26, 2022
Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares climbed 46.2% to close at $22.68 on Tuesday after the company unveiled topline data for momelotinib in myelofibrosis patients...
Via
Benzinga
22 Stocks Moving in Wednesday's Pre-Market Session
December 08, 2021
Gainers Daré Bioscience, Inc. (NASDAQ: DARE) rose 45.2% to $3.08 in pre-market trading after the company reported the FDA approval of XACIATO Vaginal Gel as a treatment...
Via
Benzinga
Exposures
Product Safety
Earnings Scheduled For May 10, 2021
May 10, 2021
Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report...
Via
Benzinga
Is Next-Generation Drug Delivery Coming to a Hospital Near You?
December 01, 2021
Photo by Anna Shvets on Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner...
Via
Benzinga
On Target: This Company Says It Delivers Drugs Exactly How You Need Them
November 15, 2021
Photo by Anna Shvets from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
46 Biggest Movers From Yesterday
October 12, 2021
Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares jumped 93.9% to close at $35.36 on Monday. The FDA removed the full clinical hold on Protagonist Therapeutics’...
Via
Benzinga
Exposures
Product Safety
Earnings Scheduled For November 8, 2021
November 08, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •...
Via
Benzinga
28 Stocks Moving In Monday's Mid-Day Session
October 11, 2021
Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares surged 85% to $33.78. The FDA removed the full clinical hold on Protagonist Therapeutics’ rusfertide clinical...
Via
Benzinga
Exposures
Product Safety
15 Stocks Moving in Monday's Pre-Market Session
October 11, 2021
Gainers Trevi Therapeutics, Inc. (NASDAQ: TRVI) rose 32.5% to $1.59 in pre-market trading after the company filed Friday to withdraw its offering of shares. Nutriband Inc. (...
Via
Benzinga
16 Stocks Moving in Tuesday's Pre-Market Session
October 05, 2021
Gainers Marine Petroleum Trust (NASDAQ: MARPS) rose 25.4% to $6.29 in pre-market trading after gaining 8% on Monday. Agrify Corporation. (NASDAQ: AGFY) rose 17.8% to $21.76 in...
Via
Benzinga
16 Stocks Moving in Wednesday's Pre-Market Session
September 29, 2021
Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) rose 29.7% to $5.42 in pre-market trading after the company reported the purchase of exclusive rights to PNP Therapeutics'...
Via
Benzinga
24 Stocks Moving in Thursday's Pre-Market Session
September 23, 2021
Gainers Amplitude Healthcare Acquisition Corporation (NASDAQ: AMHC) rose 61.8% to $16.55 in pre-market trading. The company disclosed that shareholders approved the business...
Via
Benzinga
46 Biggest Movers From Yesterday
September 15, 2021
Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share. Onion Global Limited...
Via
Benzinga
Why Matinas BioPharma's Stock Is Trading Higher Today
September 14, 2021
Matinas BioPharma Hldgs (AMEX:MTNB) shares are trading higher on continued upward momentum after the company yesterday announced data in the ongoing EnACT trial of MAT2203...
Via
Benzinga
36 Stocks Moving In Tuesday's Mid-Day Session
September 14, 2021
Gainers FuelCell Energy, Inc. (NASDAQ: FCEL) shares jumped 26% to $7.08 after the company reported better-than-expected Q3 results. BELLUS Health Inc. (NASDAQ: BLU) shares...
Via
Benzinga
20 Stocks Moving in Tuesday's Pre-Market Session
September 14, 2021
Gainers Communications Systems, Inc. (NASDAQ: JCS) rose 34.8% to $9.15 in pre-market trading as the company declared a special dividend of $3.50 per share. DatChat, Inc. (NASDAQ...
Via
Benzinga
Matinas BioPharma Stock Jumps After Meningitis Candidate Data
September 13, 2021
Matinas BioPharma Holdings Inc (NYSE: MTNB) has announced positive data from the first two cohorts of the Phase 2 EnACT trial of MAT2203 (oral amphotericin B) for...
Via
Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
August 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
COVID-19
Matinas BioPharma Hldgs Earnings Preview
August 09, 2021
Matinas BioPharma Hldgs (AMEX:MTNB) announces its next round of earnings this Tuesday, August 10. Here is Benzinga's everything-that-matters guide for this Tuesday's Q2 earnings...
Via
Benzinga
Matinas BioPharma Hldgs: Return On Capital Employed Insights
June 23, 2021
Matinas BioPharma Hldgs (AMEX:MTNB) reported Q1 sales of $33.33 thousand. Earnings fell to a loss of $6.35 million, resulting in a 2.09% decrease from last quarter. Matinas...
Via
Benzinga
Return On Capital Employed Overview: Matinas BioPharma Hldgs
June 07, 2021
Matinas BioPharma Hldgs (AMEX:MTNB) reported Q1 sales of $33.33 thousand. Earnings fell to a loss of $6.35 million, resulting in a 2.09% decrease from last quarter. In Q4, Matinas...
Via
Benzinga
Matinas BioPharma Hldgs's Earnings: A Preview
May 07, 2021
Matinas BioPharma Hldgs (AMEX:MTNB) announces its next round of earnings this Monday, May 10. Here is Benzinga's everything-that-matters guide for this Monday's Q1 earnings...
Via
Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
May 09, 2021
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...
Via
Benzinga
Exposures
COVID-19
Product Safety
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.